지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.5
- 수록면
- 380 - 389 (10page)
이용수
초록· 키워드
오류제보하기
Metabolic syndrome (MS) refers to a clustering of at least three of the following medical conditions: high blood pressure, abdominal obesity, hyperglycemia, low high-density lipoprotein level, and high serum triglycerides. MS is related to a wide range of diseases which includes obesity, diabetes, insulin resistance, cardiovascular disease, dyslipidemia, or non-alcoholic fatty liver disease. There remains an ongoing need for improved treatment strategies for MS. The most important risk factors are dietary pattern, genetics, old age, lack of exercise, disrupted biology, medication usage, and excessive alcohol consumption, but pathophysiology of MS has not been completely identified. Korean Red Ginseng (KRG) refers to steamed/dried ginseng, traditionally associated with beneficial effects such as anti-inflammation, anti-fatigue, anti-obesity, anti-oxidant, and anti-cancer effects. KRG has been often used in traditional medicine to treat multiple metabolic conditions. This paper summarizes the effects of KRG in MS and related diseases such as obesity, cardiovascular disease, insulin resistance, diabetes, dyslipidemia, or non-alcoholic fatty liver disease based on experimental research and clinical studies.
목차
ABSTRACT
1. Introduction
2. Metabolic syndrome
3. Korean Red Ginseng
4. Metabolic syndrome and Korean Red Ginseng
5. Conclusion
References
참고문헌 (108)
참고문헌 신청
Aguilar M / 2015 / Prevalence of the metabolic syndrome in the United States, 2003-2012 / JAMA 313:1973~1974
Nazara Otero CA / 2016 / Metabolic syndrome:diagnosis and management. An update / Clin Investig Arterioscler 28:230~231
Lee HJ / 2009 / Korean red ginseng(Panax ginseng)improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats / Metabolism 58:1170~1177
Park SJ / 2019 / Anti-diabetic properties of different fractions of Korean red ginseng / J Ethnopharmacol 236:220~230
박태영 / 2017 / Effect of Korean Red Ginseng in chronic liver disease / Journal of Ginseng Research 41(4):450~455
Nazara Otero CA / 2016 / Metabolic syndrome:diagnosis and management. An update / Clin Investig Arterioscler 28:230~231
Lee HJ / 2009 / Korean red ginseng(Panax ginseng)improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats / Metabolism 58:1170~1177
Park SJ / 2019 / Anti-diabetic properties of different fractions of Korean red ginseng / J Ethnopharmacol 236:220~230
박태영 / 2017 / Effect of Korean Red Ginseng in chronic liver disease / Journal of Ginseng Research 41(4):450~455
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Clinical and Molecular Hepatology
2023 .01
-
Reply to Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Clinical and Molecular Hepatology
2023 .01
-
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
-
Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome
Pediatric Gastroenterology, Hepatology & Nutrition
2020 .01
-
Effect of Korean Red Ginseng in chronic liver disease
Journal of Ginseng Research
2017 .10
-
The Risk of Abdominal Obesity according to the Degree of Non- Alcoholic Fatty Liver Disease in Korean Men
Journal of Korean Medical Science
2016 .01
-
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
-
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
-
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology
2022 .10
-
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
Clinical and Molecular Hepatology
2023 .04
-
The antioxidant activities of Korean Red Ginseng (Panax ginseng) and ginsenosides: A systemic review through in vivo and clinical trials
Journal of Ginseng Research
2021 .01
-
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
Gut and Liver
2022 .07
-
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Clinical and Molecular Hepatology
2023 .04
-
Topical Issue: Acu-obesity and Diabetes
Journal of Acupuncture & Meridian Studies
2016 .01
-
The beneficial potential of ginseng for menopause
Journal of Ginseng Research
2024 .09
-
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Clinical and Molecular Hepatology
2022 .07
-
Effects of Panax ginseng on hyperglycemia, hypertension, and hyperlipidemia: A systematic review and meta-analysis
Journal of Ginseng Research
2022 .03
-
The Role of T Cells in Obesity-Associated Inflammation and Metabolic Disease
Immune Network
2022 .02
-
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology
2024 .04
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2021-524-001683693